Evidence map›Paper›PMID 41229974›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2025

Comparison of short- and long-term outcomes of robotic

Hualong Zheng, Zhiwei Zheng, Honghong Zheng, Taiyuan Li, Linghua Wei, Li Zhang, Junjun She, Baoqing Jia, Xingan Qin, Shuangyi Ren and 6 more

Abstract read
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hualong Zheng *Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Zhiwei Zheng *Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Honghong Zheng *Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Taiyuan Li *Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang 330000, China.
Linghua WeiDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Li ZhangDepartment of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300000, China.
Junjun SheDepartment of General Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710000, China.
Baoqing JiaDepartment of General Surgery, the First Medical Center, PLA General Hospital, Beijing 100039, China.
Xingan QinDepartment of Gastrointestinal Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
Shuangyi RenDepartment of General Surgery, the Second Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Hongliang YaoDepartment of General Surgery, the Second Xiangya Hospital, Central South University, Changsha 410000, China.
Zhen XueDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Lingkang ZhangDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Jiabin WangDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Changming HuangDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
Ping LiDepartment of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Robotic gastrectomy (RG) is increasingly used in the treatment of gastric cancer. However, studies on patients with clinical serosa-invasive (cT4a) gastric cancer remain scarce. This study aimed to compare the short- and long-term outcomes of RG and laparoscopic gastrectomy (LG) in the treatment of stage cT4a gastric cancer. Methods: A retrospective analysis was conducted on the clinical data of patients with stage cT4a gastric cancer diagnosed and treated at eight high-volume tertiary teaching hospitals in China from 2016 to 2019. Propensity score matching (PSM) analysis and inverse probability of treatment weighting (IPTW) analysis was used to adjust for the imbalance in baseline characteristics. The primary research endpoint was the 3-year overall survival (OS) and disease-free survival (DFS). The secondary research endpoint was intraoperative outcomes and postoperative complications. Results: After IPTW and PSM adjustments, baseline characteristics between the RG and LG groups were comparable [standardized mean difference (SMD) <0.10]. Post-PSM analysis revealed that the RG group exhibited longer operative time (P<0.001), lower postoperative complication rates (P<0.001), shorter postoperative hospital stays (P=0.037), and earlier initiation of adjuvant chemotherapy (P=0.041) compared with the LG group. Survival analysis demonstrated comparable 3-year OS (P=0.110) and DFS (P=0.088) in the PSM cohort, whereas the IPTW cohort showed superior OS (P=0.030) and DFS (P=0.046) for RG. No significant differences were observed in overall recurrence rates or recurrence sites between groups. Conclusions: For patients with stage cT4a gastric cancer, compared with the LG group, the RG group had shorter postoperative hospital stay, lower incidence of postoperative complications, earlier postoperative adjuvant chemotherapy, and no worse long-term efficacy.

Indexed as

cT4a gastric cancerlaparoscopic gastrectomylong-term outcomesrobotic gastrectomyshort-term outcomes

Identifiers

PMID41229974
PMCPMC12603632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.